Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

157.70
-3.7700-2.33%
Post-market: 158.010.3100+0.20%19:58 EDT
Volume:3.38M
Turnover:536.85M
Market Cap:244.59B
PE:23.61
High:161.33
Open:160.77
Low:157.54
Close:161.47
52wk High:212.71
52wk Low:153.41
Shares:1.55B
Float Shares:1.50B
Volume Ratio:1.34
T/O Rate:0.23%
Dividend:3.16
Dividend Rate:2.01%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:4.86
PE(LYR):24.11

Loading ...

Astrazeneca Says Cancer Drugs Enhertu, Tagrisso Show Survival Benefits in Late-Stage Trials

MT Newswires Live
·
Sep 14

AstraZeneca Breast-Cancer Drug Misses Goal in Late-Stage Trial

Dow Jones
·
Sep 14

Olema selloff on AstraZeneca miss a buying opportunity, says Citi

TIPRANKS
·
Sep 14

Movement Alert|AstraZeneca PLC Falls 3.65% in After-Hours Trading, Disappointing Phase 3 Clinical Trial Results Weigh on Shares

Market Focus
·
Sep 12

Astrazeneca's Breast Cancer Drug Fails Late-Stage Trial

Reuters
·
Sep 12

AstraZeneca PLC Stock Rises Thursday, Outperforms Market

Dow Jones
·
Sep 11

European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading

MT Newswires Live
·
Sep 10

AstraZeneca (AZN) Receives a Buy from Berenberg Bank

TIPRANKS
·
Sep 10

AstraZeneca Shares Look Set for Swift Recovery

Dow Jones
·
Sep 09

AstraZeneca's COPD Drug Data to Boost Sales Outlook

Dow Jones
·
Sep 09

RBC Initiates AstraZeneca at Outperform With GBP145 Price Target

MT Newswires Live
·
Sep 09

RBC Capital Reaffirms Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
Sep 09

Dow Jones Top Company Headlines at 1 PM ET: Amazon Sued for Allegedly Discriminating Against Pregnant Workers | GE ...

Dow Jones
·
Sep 09

AstraZeneca Falls Tuesday, Underperforms Market

Dow Jones
·
Sep 09

Top Midday Stories: GE Aerospace to Acquire Consolidated Precision Products; Qualcomm Issues Share Warrant to Amazon

MT Newswires Live
·
Sep 08

Dow Jones Top Company Headlines at 11 am ET: GE Aerospace to Buy Consolidated Precision Products | GameStop ...

Dow Jones
·
Sep 08

Amgen Says Phase 3 Study Meets Primary Endpoint in Small Cell Lung Cancer

MT Newswires Live
·
Sep 08

AstraZeneca Says Lung-Disease Drug Shows Benefits Across Patient Groups

Dow Jones
·
Sep 08

AstraZeneca Says Tozorakimab Cuts COPD Exacerbations in Phase 3 Trials

MT Newswires Live
·
Sep 08

Guardant Health's Breast Cancer Diagnostic Approved by US FDA

MT Newswires Live
·
Sep 08